EIM
KITE

Essex Investment Management’s Kite Pharma, Inc. KITE Stock Holding History

Essex Investment Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-70,603
Closed -$7.32M – 395
2017
Q2 		$7.32M Sell
70,603
-557
-0.8% -$45.5K 1.05% 17
2017
Q1 		$5.58M Buy
71,160
+5,273
+8% +$326K 0.88% 22
2016
Q4 		$2.95M Buy
65,887
+52,852
+405% +$2.59M 0.49% 46
2016
Q3 		$728K Buy
+13,035
New +$726K 0.12% 215

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Essex Investment Management's KITE Position: Q3 2017 in Review

Essex Investment Management sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 70,603 shares — an estimated $7.32M sold.

Essex Investment Management first reported a position in KITE in Q3 2016 and held it in 4 quarters. The position peaked at $7.32M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Essex Investment Management reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Essex Investment Management sold 70,603 Kite Pharma, Inc. shares in Q3 2017, an estimated $7.32M.
  • Essex Investment Management first reported a position in Kite Pharma, Inc. in Q3 2016 and held it in 4 quarters.
  • Essex Investment Management's Kite Pharma, Inc. position peaked at $7.32M in Q2 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Essex Investment Management's 13F filing for Q3 2017, filed 30 Oct 2017.